Technology and Platforms

Our innovations in pre-analytical sample preparation and sequencing together with bespoke bio-informatics for multi-modality analyses of circulating tumour and viral DNA allow early cancer detection from a simple blood draw.

We combine affordable rapid-point-of-care carrier lateral flow testing and non-invasive pre-natal diagnosis of haemoglobinopathies from maternal plasma into a comprehensive suite of precise diagnostic tests for the most common monogenic disease worldwide.

We partner with different sequencing providers and biotechnology firms to achieve cost-effectiveness and rapid turn-around times in a clinically accredited environment.